According to a U.S. Food and Drug Administration (FDA) announcement, New England Compounding Pharmacy, Inc., d.b.a. New England Compounding Center (NECC) has recalled all of its drugs and medical products due to potential risk of contamination. The massive recall follows a nationwide meningitis outbreak attributed to contaminated preservative-free methylprednisolone acetate, a steroid produced and distributed by NECC.
Read More
Firm Blog
New Jersey Cancer Patients Now Have Access to Proton Therapy
According to an article posted on NJSpotlight.com, cancer patients in New Jersey will no longer need to travel to Philadelphia to receive a relatively new form of cancer treatment called proton therapy, which treats the cancer cells with minimal impact to the surrounding healthy tissue. There are now two proton therapy facilities in New Jersey, one
Read More
Valley National Bank Sponsors Walk, Raises More Than $80,000 for Breast Cancer Research
According to an article posted on NJ.com, Valley National Bank hosted its fourth annual Valley Goes Pink! breast cancer walk on Saturday, October 6, 2012 in Wayne, New Jersey. Over 1,000 Valley National Bank employees, friends, and family members walked to raise funds to benefit the Cure Breast Cancer Foundation (CBCF), an organization that supports Memorial
Read More
American Cancer Society Conducting Nationwide Recruitment for 20-Year Study
New Jersey cancer patients have the opportunity to take part in the largest study ever conducted by the American Cancer Society, according to an article posted on NJ.com. The Cancer Prevention Study-3 will track 300,000 people across the nation for a minimum of 20 years to analyze how genetics, environment, and lifestyle contribute to the cause
Read More
New Study Reveals Increased Risk of Bladder Cancer for Certain Diabetes Drugs
A new study by the University of Pennsylvania, published in the Journal of the National Cancer Institute (JNCI), assessed the risk of bladder cancer in type 2 diabetes patients using pioglitazone, which is a thiazolidinedione (TZD) drug like Actos. After a retrospective cohort study of 60,000 type 2 diabetes patients taking TZD drugs or sulfonylurea (SU) drugs
Read More
